Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 13, 2008

Primary Completion Date

January 29, 2011

Study Completion Date

November 26, 2012

Conditions
Breast CancerEstrogen Receptor-Positive Breast CancerBreast Cancer, Estrogen Receptor-PositiveER+ Breast Cancer
Interventions
DRUG

entinostat

Entinostat 5 mg tablet orally once per week

DRUG

exemestane

Exemestane 25 mg tablet orally once daily

DRUG

Placebo

Placebo-matching entinostat tablet orally once per week

Trial Locations (38)

Unknown

California Cancer Care, Greenbrae

Moores UCSD Cancer Center, La Jolla

Scripps Health, La Jolla

University of Colorado, Aurora

Rocky Mountain Cancer Center, Denver

Florida Cancer Specialists, Fort Myers

Memorial Cancer Institute, Hollywood

University of Southern Florida -Moffitt Cancer Center, Tampa

Palm Beach Cancer Institute, West Palm Beach

Medical College of Georgia, Augusta

Indiana University Indiana Cancer Pavilion, Indianapolis

University of Maryland Greenebaum Cancer Center, Baltimore

Kansas City Cancer Center, Kansas City

Hematology-Oncology Associates of Northern New Jersey, Morristown

Carolinas Healthcare System Clinical Trials, Charlotte

Wake Forest University Baptist Medical Center, Winston-Salem

Oncology Hematology Care, Cincinnati

Cancer Centers of the Carolinas, Greenville

Chattanooga Oncology Hematology Associates, Chattanooga

Sarah Cannon Cancer Center, Nashville

South Texas Cancer Center, McAllen

Virginia Cancer Institute, Richmond

Columbia Basin Hematology & Oncology, Kennewick

Puget Sound Cancer Center, Seattle

RSM Durham Regional Cancer Center - Lakeridge Health, Oshawa

St. Joseph's Health Centre, Toronto

Fakultni nemocnice Olomouc, Olomouc

Radiologicke centrum Multiscan, s.r.o., Pardubice

Fakultani Nemocnice Kralavske Vinohadry, Praque

Allami Egeszseguegi Koezpont, Budapest

Semmelweis Egyetem, Budapest

Radiologicke centrum Multiscan, Debrecen

Clinfan Ltd SMO, County Hospital Szekszard, Szekszárd

Arkhangelsk Regional Clinical Oncology Dispensary, Arkhangelsk

Blokhin Russian Oncology Research Center of Russian Academy of Medical Sciences, Moscow

Leningrad Regional Oncology Dispensary, Saint Petersburg

Russian Research Centre of Radiology and Surgery, Saint Petersburg

Stavropol Territory Clinical Oncology Dispensary, Stavropol

Sponsors
All Listed Sponsors
lead

Syndax Pharmaceuticals

INDUSTRY

NCT00676663 - Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer | Biotech Hunter | Biotech Hunter